Cutler Group LP Clearside Biomedical, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$4.83 - $7.2 $34,293 - $51,120	-7,100 Reduced 87.65%	1,000 $0
Q2 2021 Jul 19, 2021	BUY	$2.32 - $5.38 $18,792 - $43,578	8,100 New	8,100 $3,000
Q3 2018 Nov 07, 2018	SELL	$6.03 - $11.24 $6,633 - $12,364	-1,100 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$8.91 - $14.54 $9,801 - $15,993	1,100 New	1,100 $0

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.